Ixprim Effervescent

Tramadol Hydrochloride, the active ingredient in Ixprim Effervescent, is an opioid analgesic presented as an effervescent tablet for oral use. Combined with paracetamol, it provides analgesic and antipyretic effects for the management of moderate to severe acute pain, including post‑operative and traumatic pain, in adult patients.

GNH USA supplies Ixprim Effervescent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ixprim Effervescent, containing tramadol and paracetamol, is indicated for pain conditions where combined opioid and non‑opioid analgesia is required.

- Moderate to severe acute pain: provides rapid relief of pain intensity. - Post‑operative pain: reduces pain after surgical procedures. - Traumatic pain: alleviates pain resulting from injuries.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Dizziness: transient light‑headedness. - Constipation: reduced bowel movements. - Headache: mild to moderate pain in the head. - Dry mouth: reduced salivation. - Sweating: increased perspiration.

Serious or Rare Side Effects: - Seizures: risk increased at high doses or with interacting drugs. - Respiratory depression: slowed breathing, especially in opioid‑naïve patients. - Allergic reactions: rash, urticaria, or anaphylaxis. - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities. - Hepatic injury: elevated liver enzymes or jaundice. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing Ixprim Effervescent, consider the following precautions: - Assess pain severity: ensure opioid therapy is justified for the level of pain. - Review respiratory history: avoid in patients with severe asthma or chronic obstructive pulmonary disease. - Monitor for dependence: limit duration and assess for signs of misuse. - Avoid concomitant MAO inhibitors: discontinue MAO inhibitors at least 14 days before use. - Adjust in hepatic impairment: consider dose reduction or alternative therapy. - Store at ambient temperature: keep in the original pack, protect from moisture.

Ixprim Effervescent may interact with several medicines. Review patient medication lists carefully.

Major Interactions (Avoid): - MAO inhibitors: risk of serotonin syndrome. - CNS depressants (benzodiazepines, alcohol): enhanced respiratory depression. - SSRIs or SNRIs: increased risk of serotonin syndrome. - CYP2D6 inhibitors (e.g., quinidine, fluoxetine): elevated tramadol plasma levels. - Warfarin: possible increased bleeding tendency.

Moderate Interactions (Monitor Closely): - Anticonvulsants (carbamazepine, phenytoin): may reduce analgesic efficacy. - Diuretics: may potentiate hypotensive effects of paracetamol. - Rifampicin: may lower plasma concentrations of both components.